MedMira Inc
XTSX:MIR

Watchlist Manager
MedMira Inc Logo
MedMira Inc
XTSX:MIR
Watchlist
Price: 0.085 CAD 6.25% Market Closed
Market Cap: 64.5m CAD
Have any thoughts about
MedMira Inc?
Write Note

MedMira Inc
Investor Relations

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Hermes Chan
Co-Founder, CEO, President & Director
No Bio Available
Mr. Markus M. Meile
Chief Financial Officer
No Bio Available
Dr. Sam Ratnam
Director of Scientific & Regulatory Affairs
No Bio Available
Stewart McKelvey
Legal Counsel
No Bio Available
Dr. Kevin D. Jones
Head of Commercialization and Senior Director of Sales & Marketing
No Bio Available

Contacts

Address
NOVA SCOTIA
Halifax
155 Chain Lake Dr.,, Suite 1
Contacts
+19024501588.0
medmira.com